• KSAN
  • Contact us
  • E-Submission

Korean J Adult Nurs : Korean Journal of Adult Nursing

OPEN ACCESS
mobile search button mobile menu button
Search
Advanced Search
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Articles

Page Path

Original Article

Hot Flashes and Hypogonadism Symptoms in Patients with Prostate Cancer Receiving Hormone Replacement Therapy

Hyun Hye Park1, Jeong Sook Park2
Korean Journal of Adult Nursing 2014;26(2):159-170.
Published online: April 30, 2014

1Dongsan Medical Center, Daegu

2College of Nursing, Keimyung University, Daegu, Korea

Corresponding author: Park, Jeong Sook College of Nursing, Keimyung University,1095 Shindang-dong, Dalsseo-gu, Daegu 704-701, Korea. Tel: +82-53-580-3907, Fax: +82-53-580-3904, E-mail: jsp544@kmu.ac.kr
• Received: August 22, 2013   • Accepted: April 4, 2014

© 2014 Korean Society of Adult Nursing

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 14 Views
  • 0 Download
  • 1 Crossref
prev next

Full Article

Download PDF Download PDF
  • Purpose
    This research investigated the degree and predictors of hot flashes and hypogonadism symptoms in patients with prostate cancer receiving hormone replacement therapy.
  • Methods
    The subjects were 111 patients with prostate cancer receiving hormone replacement therapy in two university hospitals located in D city. The measurement tools included Hot Flash Diary and AMS (Aging Male's Symptoms rating scales). The data were analyzed using t-test, ANOVA, and binary logistic regression analysis.
  • Results
    The percentage of patients who experienced hot flashes among the participants was 14.4%. The predictors for hot flashes were eating irregularly, having coffee frequently and the types of hormone. The average score of hypogonadism symptom was 2.16 out of five-point scale and the highest score of hypogonadism symptom was the sexual symptoms (2.77 out of five-point scale). The predictors for hypogonadism symptom were eating habits and years of having the illness.
  • Conclusion
    These findings provide the information that irregularly eating habit was an important factor in hot flashes and hypogonadism symptoms of the participants. Therefore the development of a nutritional education encouraging regular meals is necessary for the given population.
  • Key Words: Prostate cancer; Hot flashes; Hypogonadism; Hormone replacement therapy
Table 1.
Characteristics of Prostate Cancer Patients Receiving Hormone Therapy with Hot Flashes (N=16)
Characteristics Categories n (%) or M±SD
Hot flush Yes 16 (14.4)
No 95 (85.6)
Hot flashes onset Before receiving treatment 4 (25.0)
When treated 9 (56.3)
After 3 months of treatment 2 (12.5)
After 6 months of treatment 1 (6.2)
How to relieve Yes 0 (0.0)
No 16 (100.0)
Hot flashes related daily interference in work (work outside the home and housework) Many times 0 (0.0)
Often 2 (12.5)
Sometimes 1 (6.2)
Not 2 (12.5)
Never 11 (68.8)
Many times 0 (0.0)
Hot flashes related daily interference in social activities (time spent with family, friends, etc.) Often 2 (12.5)
Sometimes 1 (6.2)
Not 2 (12.5)
Never 11 (68.8)
Hot flashes diary Hot flashes score 43.63±25.20
Hot flashes frequency (times/1 day) 2.88±1.82
Hot flashes duration (minutes/1 time) 4.38±4.08
Sweat score 41.50±31.76
Palpitation score 11.00±20.16
Table 2.
Characteristics of Prostate Cancer Patients Receiving Hormone Therapy with Hypogonadism Symptoms (N=111)
Categories Question n (%) or M±SD
Total average score   2.16±0.66
Psychological factor Irritability 1.64±0.98
Nervousness 1.80±1.06
Anxiety 1.62±1.04
Depressive mood 1.84±1.11
Feeling burnt out, having hit rock-bottom 1.89±1.04
Subtotal score 1.76±1.05
Somatovegetative factor Decline in your feeling of general well-being 1.90±1.00
Joint pain and muscular ache 1.88±1.01
Excessive sweating 2.00±1.25
Sleep problems 2.15±1.27
Increased need for sleep, often feeling tired 1.95±1.17
Physical exhaustion / lacking vitality 2.07±1.06
Decrease in muscular strength 2.18±1.13
Subtotal score 2.02±1.13
Sexual factor Feeling that you have passed your peak 2.39±1.19
Decrease in beard growth 1.66±0.96
Decrease in ability/frequency to perform sexually 3.28±1.53
Decrease in the number of morning erections 3.29±1.54
Decrease in sexual desire/libido 3.24±1.55
Subtotal score 2.78±1.52
Table 3.
Hot Flashes and Hypogonadism Symptoms according to General Characteristics in Prostate Cancer Patients Receivin Hormone Therapy (N=111
Characteristics Categories Hot flashes DTS
Yes (n=16) No (n=95) x2 (p†) M±SD t or F (p) Scheffé
n (%) n (%)
Age (year) 60~69 5 (31.2) 16 (16.8) 2.62 2.42±0.61 2.32
70~79 9 (56.3) 53 (55.8) (.263) 2.13±0.67 (.103)
80~89 2 (12.5) 26 (27.4)   2.02±0.65  
M±SD 75.2±6.71      
Body Mass Index Normal weight 8 (50.0) 41 (43.2) 0.43 2.15±0.60 0.72
Overweight 4 (25.0) 31 (32.6) (.888) 2.08±0.74 (.488)
Obesity 4 (25.0) 23 (24.2)   2.28±0.67  
Spouse Have 13 (81.3) 77 (81.1) 2.28 2.20±0.66 1.36
Have not 3 (18.7) 18 (18.9) (.319) 1.98±0.68 (.176)
Education lever ≤Elementary school 3 (18.7) 28 (29.5) 0.88 2.13±0.56 0.32
Middle school 6 (37.5) 28 (29.5) (.701) 2.11±0.73 (.720)
≥High school 7 (43.8) 39 (41.0)   2.22±0.69  
Religion Protestant & catholic 4 (25.0) 21 (22.1) 1.28 2.09±0.78 0.17
Buddhism 7 (43.8) 31 (32.6) (.510) 2.19±0.66 (.839)
None 5 (31.2) 43 (45.3)   2.17±0.62  
Smoking status Smoker 4 (25.0) 15 (15.8) 0.81 2.35±0.69 1.35
Nonsmoker 12 (75.0) 80 (84.2) (.471) 2.12±0.65 (.178)
Drinking status (1 week) Rare 9 (56.3) 66 (69.5) 1.61) 2.07±0.63 2.35)
≤1 time 5 (31.2) 18 (18.9) (.450) 2.41±0.75 (.100)
≥2 times 2 (12.5) 11 (11.6)   2.21±0.64  
Eating habits Regular 11 (68.8) 69 (72.6) 6.92 2.04±0.63 16.20
Average 2 (12.5) 24 (25.3) (.029) 2.34±0.64 (＜.001)
Irregular 3 (18.7) 2 (2.1)   3.16±0.30 a＞b, c
Nutrition Balance 10 (62.5) 36 (37.9) 3.14 2.09±0.67 1.75
Average 5 (31.3) 43 (45.3) (.217) 2.29±0.59 (.178)
Unbalance 1 (6.2) 16 (16.8)   1.98±0.80  
Feeding habit Vegetarian 9 (56.3) 34 (35.8) 2.41 2.33±0.66 -2.17
A meat-eater 7 (43.7) 61 (64.2) (.166) 2.05±0.63 (.032)
Taste preference Evenly among all 10 (62.5) 61 (64.3) 0.49 2.10±0.68 0.74
Sweetness 4 (25.0) 18 (18.9) (.855) 2.22±0.62 (.476)
The others 2 (12.5) 16 (16.8)   2.31±0.66  
Water intake (1 day) ＜1 L 5 (31.2) 36 (37.9) 1.78 2.22±0.58 2.73
1~2 L 7 (43.8) 47 (49.5) (.396) 2.03±0.68 (.070)
＞2 L 4 (25.0) 12 (12.6)   2.45±0.74  
Coffee intake (1 day) ≤1 cup 4 (25.0) 56 (59.0) 8.09 2.12±0.66 1.12
2 cups 5 (31.2) 24 (25.2) (.013) 2.09±0.71 (.329)
≥3 cups 7 (43.8) 15 (15.8)   2.35±0.61  
Regular exercise (1 week) ＜3 times 5 (31.2) 25 (26.3) 0.16 2.05±0.58 -1.01
≥3 times 11 (68.8) 70 (73.7) (.762) 2.20±0.69 (.314)
Duration of treatment since diagnosis (year) ＜1 9 (56.3) 37 (38.9) 1.52 2.01±0.63 3.50
1~5 5 (31.2) 41 (43.2) (.457) 2.18±0.64 (.033)
＞5 2 (12.5) 17 (17.9)   2.48±0.70 a＜c
Duration of hormone therapy (year) ＜1 10 (62.5) 47 (49.5) 0.93 2.05±0.64 -1.84
≥1 6 (37.5) 48 (50.5) (.422) 2.28±0.68 (.068)
Kinds of hormones LHRH agonist 14 (87.5) 50 (52.6) 0.68 2.22±0.65 1.10
Antiandrogen 2 (12.5) 45 (47.4) (.012) 2.08±0.69 (.272)
Additional treatment No 10 (62.5) 56 (59.0) 1.69 2.21±0.69 0.50
Yes 4 (25.0) 16 (16.8) (.417) 2.04±0.65 (.606)
Operation radiotherapy y 2 (12.5) 23 (24.2)   2.13±0.61  

DTS=decreased testosterone symptoms; LHRH=luteinizing hormone releasing hormone.

†Obtained by Fisher's exact test.

Table 4.
Influencing Factors of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy by Binary Logistic Regression Analysis (N=111)
Characteristics Categories B Wald OR (95% CI) p
BMI Obesity -0.36 0.21 1.44 (0.30~6.80) .643
Overweight -0.30 0.00 0.96 (0.20~4.52) .964
Normal weight     1  
Smoking status Smoker -0.40 0.26 0.66 (0.14~3.11) .606
Nonsmoker     1  
Eating habits Irregular 2.48 3.93 11.95 (1.02~138.90) .047
Average -0.31 0.12 0.73 (0.13~4.02) .719
Regular     1  
Coffee intake (1 day) ≥3 cups 2.18 7.12 8.89 (1.78~44.24) .008
2 cups 0.95 1.44 2.58 (0.54~12.18) .230
≤1 cup     1  
Regular exercise (1 week) ≥3 times 0.20 0.08 1.22 (0.30~4.92) .771
＜3 times     1  
Kinds of hormones LHRH agonist 2.03 5.70 7.61 (1.44~40.25) .017
Antiandrogen     1  

OR=odds ratio; CI=confidence interval; BMI=body mass index; LHRH=luteinizing hormone releasing hormone.

  • Akaza H.. 2004;Advanced prostate cancer treatment guidelines: A global perspective; trends of hormone therapy in Japan. British Journal of Urology International. 94(3):5.
  • Baber R., Hickey M., Kwik M.. 2005;Therapy for menopausal symptoms during and after treatment for breast cancer: Safety considerations. Drug Safety. 28(12):1085–-1100.
  • Carr M. C.. 2003;The emergence of the metabolic syndrome with menopause. The Journal of Clinical Endocrinology and Metabolism. 88(6):2404–-2411.
  • Choi H. C., Cho B. L., Oh B. J., Kim H. S.. 2011;Physical activity and exercise for men with late onset hypogonadism. Korean Association of Medical Journal Editors. 29(3):181–-190.
  • Cochran C. J., Gallicchio L., Miller S. R., Zacur H., Flaws J. A.. 2008;Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstetrics and Gynecology. 112(5):1037–-1044.
  • Daig I., Heinemann L. A., Kim S., Leungwattanakij S., Badia X., Myon E., et al. 2003;The Aging Males' Symptoms (AMS) scale: Review of its methodological characteristics. Health and Quality of Life Outcomes. 1(77):1–-12.
  • Dormire S. L., Reame N.. 2003;Hot flash variation in response to experimental manipulation of blood glucose in menopausal women. Nursing Research. 52(5):338–-343.
  • Dormire S., Howharn C.. 2007;The effect of dietary intake on hot flashes in menopausal women. Journal of Obstetric, Gynecologic, and Neonatal Nursing. 36(3):255–-262.
  • Engstrom C. A.. 2008;Hot flashes in prostate cancer: State of the science. American Journal of Men's Health. 2(2):122–-132.
  • Freeman E. W., Sherif K.. 2007;Prevalence of hot flushes and night sweats around the world: A systematic review. Climacteric. 10(3):197–-214.
  • Frisk J.. 2010;Managing hot flushes in men after prostate cancer: A systematic review. Maturitas. 65(1):15–-22.
  • Gold E. B., Colvin A., Avis N., Bromberger J., Greendale G. A., Powell L., et al. 2006;Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women's health across the nation. American Journal of Epidemiology. 96(7):1226–-1235.
  • Gold E. B., Sternfeld B., Kelsey J. L., Brown C., Mouton C., Reame N., et al. 2000;Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. American Journal of Epidemiology. 152(5):463–-473.
  • Greendale G. A., Gold E. B.. 2005;Lifestyle factors: Are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? The American Journal of Medicine. 118(Suppl 12B):148–-154.
  • Grunfeld E. A., Halliday A., Martin P., Drudqe-Coates L.. 2012;Andropause syndrome in men treated for metastatic prostate cancer. Cancer Nursing. 35(1):63–-69.
  • Hanisch L. J., Gooneratne N. S., Soin K., Gehrman P. R., Vaughn D. J., Coyne J. C.. 2011;Sleep and daily functioning during androgen deprivation therapy for prostate cancer. European Journal of Cancer Care. 20(4):549–-554.
  • Hankinson S. E., Willett W. C., Manson J. E., Hunter D. J., Colditz G. A., Stampfer M. J.. 1995;Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. Journal of the National Cancer Institute. 68(17):1297–-1302.
  • Heinemann L. A., Zimmermann T., Vermeulen A., Thiel C.. 1999;A new ‘Aging Male's Symptoms' (AMS) rating scale. The Aging Male. 2(2):105–-114.
  • Jun S. S., Kim D. H., Kim M. Y.. 2010;Sleep disturbance in prostate cancer patients. The Korean Journal of Fundamentals of Nursing. 17(2):169–-176.
  • Jung G. H., Suh H. S., Kim K. G., Hwang I. C., Lee K. S.. 2009;Factors Which May Influence Vasomotor Symptoms in Menopausal and Perimenopausal Women. The Journal of the Korean Society of Menopause. 15(3):164–-171.
  • Jung S. K., Kim D. I.. 2008;Clinical trial to evaluate the hot flush relief efficacy and safety of Yiseontanggami in climacteric women with hot flushes. The Journal Of Oriental Gynecology. 21(3):75–-89.
  • Kandiah J., Amend V.. 2010;An exploratory study on perceived relationship of alcohol, caffeine, and physical activity on hot flashes in menopausal women. Health. 2(9):989–-996.
  • Kaplan M., Mahon S., Cope D., Keating E., Hill S., Jacobson M.. 2011;Putting evidence in to practice: Evidence-based interventions for hot flashes resulting form cancer therapies. Clinical Journal of Oncology Nursing. 15(2):149–-157.
  • Kim S. K., Sunwoo J. G.. 2007;The analysis of the dietary factors related to climacteric symptoms in middle-aged women. The Korean Society of Community Nutrition. 12(1):25–-39.
  • Kim T. S., Kang S. H., Rhew H. Y.. 2009;Efficacy of androgen deprivation therapy in patients with clinically localized prostate cancer. Korean Journal of Urology. 50(11):1073–-1077.
  • Lee J. O., Kang S. G., Kim S. H., Park S. J., Song S. W.. 2011;The relationship between menopausal symptoms and heart rate variability in middle aged women. Korean Journal of Family Medicine. 32(5):299–-305.
  • Loblaw D. A., Virgo K. S., Nam R., Somerfield M. R., Ben-Josef E., Mendelson D. S., et al. 2007;Initial hormonal management of androgen sensitive metastatic, recurrent, or progressive prostate cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline. Journal of Clinical Oncology. 25(12):1596–-1605.
  • National Cancer Information Center. 2013;2010 Cancer incidence rate & treatment and side effects of prostate cancer April 29, 2013 cited,.http://www.cancer.go.kr.
  • Oncology Nursing Society. 2013;ONS PEP -putting evidence into practice: Hot flashes Nov 16, 2013 cited.http://www.ons/org.
  • Pimenta F., Leal I., Maroco J., Ramos C.. 2011;Perceived control, lifestyle, health, socio-demographic factors and menopause: Impact on hot flashes and night sweats. Maturitas. 69(4):338–-342.
  • Sievert L. L., Morrison L., Brown D. E., Reza A. M.. 2007;Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause. 14(2):261–-269.
  • Sim J. E., Paik H. Y., Moon H. K.. 2007;Breakfast consumption pattern, diet quality and health outcomes in adults from 2001 national health and nutrition survey. The Korean Journal Nutrition. 40(5):451–-462.
  • Tan R. S., Philip P. S.. 1999;Perceptions of and risk factors for andropause. Archives of Andrology. 43(3):227–-233.
  • Yun M. H., Kim H. J.. 2011;A study on relations among general characteristics, lifestyle habits, and menopausal symptoms measurement indicators during treatment for hot flush in menopausal women. The Journal of Oriental Obstetrics & Gynecology. 24(4):114–-125.
  • Yun M. H., Yu S. J., Kim H. J.. 2011;A study on relations between hot flush and the Kupperman's Index, MENQOL, MRS during treatment for hot flush in menopausal women. The Journal of Oriental Obstetrics & Gynecology. 24(1):87–-98.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Knowledge, Health Beliefs and Screening Status of Prostate Cancer among Middle-Aged and Elderly Men
      Eunjoo Lee, Youngsuk Park, Jeongsook Park
      Open Journal of Nursing.2016; 06(09): 672.     CrossRef

    Download Citation

    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:

    Include:

    Hot Flashes and Hypogonadism Symptoms in Patients with Prostate Cancer Receiving Hormone Replacement Therapy
    Korean J Adult Nurs. 2014;26(2):159-170.   Published online April 30, 2014
    DOI: https://doi.org/10.7475/kjan.2014.26.2.159
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Hot Flashes and Hypogonadism Symptoms in Patients with Prostate Cancer Receiving Hormone Replacement Therapy
    Korean J Adult Nurs. 2014;26(2):159-170.   Published online April 30, 2014
    DOI: https://doi.org/10.7475/kjan.2014.26.2.159
    Close
    Hot Flashes and Hypogonadism Symptoms in Patients with Prostate Cancer Receiving Hormone Replacement Therapy
    Hot Flashes and Hypogonadism Symptoms in Patients with Prostate Cancer Receiving Hormone Replacement Therapy

    Characteristics of Prostate Cancer Patients Receiving Hormone Therapy with Hot Flashes (N=16)

    Characteristics Categories n (%) or M±SD
    Hot flush Yes 16 (14.4)
    No 95 (85.6)
    Hot flashes onset Before receiving treatment 4 (25.0)
    When treated 9 (56.3)
    After 3 months of treatment 2 (12.5)
    After 6 months of treatment 1 (6.2)
    How to relieve Yes 0 (0.0)
    No 16 (100.0)
    Hot flashes related daily interference in work (work outside the home and housework) Many times 0 (0.0)
    Often 2 (12.5)
    Sometimes 1 (6.2)
    Not 2 (12.5)
    Never 11 (68.8)
    Many times 0 (0.0)
    Hot flashes related daily interference in social activities (time spent with family, friends, etc.) Often 2 (12.5)
    Sometimes 1 (6.2)
    Not 2 (12.5)
    Never 11 (68.8)
    Hot flashes diary Hot flashes score 43.63±25.20
    Hot flashes frequency (times/1 day) 2.88±1.82
    Hot flashes duration (minutes/1 time) 4.38±4.08
    Sweat score 41.50±31.76
    Palpitation score 11.00±20.16

    Characteristics of Prostate Cancer Patients Receiving Hormone Therapy with Hypogonadism Symptoms (N=111)

    Categories Question n (%) or M±SD
    Total average score   2.16±0.66
    Psychological factor Irritability 1.64±0.98
    Nervousness 1.80±1.06
    Anxiety 1.62±1.04
    Depressive mood 1.84±1.11
    Feeling burnt out, having hit rock-bottom 1.89±1.04
    Subtotal score 1.76±1.05
    Somatovegetative factor Decline in your feeling of general well-being 1.90±1.00
    Joint pain and muscular ache 1.88±1.01
    Excessive sweating 2.00±1.25
    Sleep problems 2.15±1.27
    Increased need for sleep, often feeling tired 1.95±1.17
    Physical exhaustion / lacking vitality 2.07±1.06
    Decrease in muscular strength 2.18±1.13
    Subtotal score 2.02±1.13
    Sexual factor Feeling that you have passed your peak 2.39±1.19
    Decrease in beard growth 1.66±0.96
    Decrease in ability/frequency to perform sexually 3.28±1.53
    Decrease in the number of morning erections 3.29±1.54
    Decrease in sexual desire/libido 3.24±1.55
    Subtotal score 2.78±1.52

    Hot Flashes and Hypogonadism Symptoms according to General Characteristics in Prostate Cancer Patients Receivin Hormone Therapy (N=111

    Characteristics Categories Hot flashes DTS
    Yes (n=16) No (n=95) x2 (p†) M±SD t or F (p) Scheffé
    n (%) n (%)
    Age (year) 60~69 5 (31.2) 16 (16.8) 2.62 2.42±0.61 2.32
    70~79 9 (56.3) 53 (55.8) (.263) 2.13±0.67 (.103)
    80~89 2 (12.5) 26 (27.4)   2.02±0.65  
    M±SD 75.2±6.71      
    Body Mass Index Normal weight 8 (50.0) 41 (43.2) 0.43 2.15±0.60 0.72
    Overweight 4 (25.0) 31 (32.6) (.888) 2.08±0.74 (.488)
    Obesity 4 (25.0) 23 (24.2)   2.28±0.67  
    Spouse Have 13 (81.3) 77 (81.1) 2.28 2.20±0.66 1.36
    Have not 3 (18.7) 18 (18.9) (.319) 1.98±0.68 (.176)
    Education lever ≤Elementary school 3 (18.7) 28 (29.5) 0.88 2.13±0.56 0.32
    Middle school 6 (37.5) 28 (29.5) (.701) 2.11±0.73 (.720)
    ≥High school 7 (43.8) 39 (41.0)   2.22±0.69  
    Religion Protestant & catholic 4 (25.0) 21 (22.1) 1.28 2.09±0.78 0.17
    Buddhism 7 (43.8) 31 (32.6) (.510) 2.19±0.66 (.839)
    None 5 (31.2) 43 (45.3)   2.17±0.62  
    Smoking status Smoker 4 (25.0) 15 (15.8) 0.81 2.35±0.69 1.35
    Nonsmoker 12 (75.0) 80 (84.2) (.471) 2.12±0.65 (.178)
    Drinking status (1 week) Rare 9 (56.3) 66 (69.5) 1.61) 2.07±0.63 2.35)
    ≤1 time 5 (31.2) 18 (18.9) (.450) 2.41±0.75 (.100)
    ≥2 times 2 (12.5) 11 (11.6)   2.21±0.64  
    Eating habits Regular 11 (68.8) 69 (72.6) 6.92 2.04±0.63 16.20
    Average 2 (12.5) 24 (25.3) (.029) 2.34±0.64 (＜.001)
    Irregular 3 (18.7) 2 (2.1)   3.16±0.30 a＞b, c
    Nutrition Balance 10 (62.5) 36 (37.9) 3.14 2.09±0.67 1.75
    Average 5 (31.3) 43 (45.3) (.217) 2.29±0.59 (.178)
    Unbalance 1 (6.2) 16 (16.8)   1.98±0.80  
    Feeding habit Vegetarian 9 (56.3) 34 (35.8) 2.41 2.33±0.66 -2.17
    A meat-eater 7 (43.7) 61 (64.2) (.166) 2.05±0.63 (.032)
    Taste preference Evenly among all 10 (62.5) 61 (64.3) 0.49 2.10±0.68 0.74
    Sweetness 4 (25.0) 18 (18.9) (.855) 2.22±0.62 (.476)
    The others 2 (12.5) 16 (16.8)   2.31±0.66  
    Water intake (1 day) ＜1 L 5 (31.2) 36 (37.9) 1.78 2.22±0.58 2.73
    1~2 L 7 (43.8) 47 (49.5) (.396) 2.03±0.68 (.070)
    ＞2 L 4 (25.0) 12 (12.6)   2.45±0.74  
    Coffee intake (1 day) ≤1 cup 4 (25.0) 56 (59.0) 8.09 2.12±0.66 1.12
    2 cups 5 (31.2) 24 (25.2) (.013) 2.09±0.71 (.329)
    ≥3 cups 7 (43.8) 15 (15.8)   2.35±0.61  
    Regular exercise (1 week) ＜3 times 5 (31.2) 25 (26.3) 0.16 2.05±0.58 -1.01
    ≥3 times 11 (68.8) 70 (73.7) (.762) 2.20±0.69 (.314)
    Duration of treatment since diagnosis (year) ＜1 9 (56.3) 37 (38.9) 1.52 2.01±0.63 3.50
    1~5 5 (31.2) 41 (43.2) (.457) 2.18±0.64 (.033)
    ＞5 2 (12.5) 17 (17.9)   2.48±0.70 a＜c
    Duration of hormone therapy (year) ＜1 10 (62.5) 47 (49.5) 0.93 2.05±0.64 -1.84
    ≥1 6 (37.5) 48 (50.5) (.422) 2.28±0.68 (.068)
    Kinds of hormones LHRH agonist 14 (87.5) 50 (52.6) 0.68 2.22±0.65 1.10
    Antiandrogen 2 (12.5) 45 (47.4) (.012) 2.08±0.69 (.272)
    Additional treatment No 10 (62.5) 56 (59.0) 1.69 2.21±0.69 0.50
    Yes 4 (25.0) 16 (16.8) (.417) 2.04±0.65 (.606)
    Operation radiotherapy y 2 (12.5) 23 (24.2)   2.13±0.61  

    DTS=decreased testosterone symptoms; LHRH=luteinizing hormone releasing hormone.

    †Obtained by Fisher's exact test.

    Influencing Factors of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy by Binary Logistic Regression Analysis (N=111)

    Characteristics Categories B Wald OR (95% CI) p
    BMI Obesity -0.36 0.21 1.44 (0.30~6.80) .643
    Overweight -0.30 0.00 0.96 (0.20~4.52) .964
    Normal weight     1  
    Smoking status Smoker -0.40 0.26 0.66 (0.14~3.11) .606
    Nonsmoker     1  
    Eating habits Irregular 2.48 3.93 11.95 (1.02~138.90) .047
    Average -0.31 0.12 0.73 (0.13~4.02) .719
    Regular     1  
    Coffee intake (1 day) ≥3 cups 2.18 7.12 8.89 (1.78~44.24) .008
    2 cups 0.95 1.44 2.58 (0.54~12.18) .230
    ≤1 cup     1  
    Regular exercise (1 week) ≥3 times 0.20 0.08 1.22 (0.30~4.92) .771
    ＜3 times     1  
    Kinds of hormones LHRH agonist 2.03 5.70 7.61 (1.44~40.25) .017
    Antiandrogen     1  

    OR=odds ratio; CI=confidence interval; BMI=body mass index; LHRH=luteinizing hormone releasing hormone.
    Table 1. Characteristics of Prostate Cancer Patients Receiving Hormone Therapy with Hot Flashes (N=16)

    Table 2. Characteristics of Prostate Cancer Patients Receiving Hormone Therapy with Hypogonadism Symptoms (N=111)

    Table 3. Hot Flashes and Hypogonadism Symptoms according to General Characteristics in Prostate Cancer Patients Receivin Hormone Therapy (N=111

    DTS=decreased testosterone symptoms; LHRH=luteinizing hormone releasing hormone.

    Obtained by Fisher's exact test.

    Table 4. Influencing Factors of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy by Binary Logistic Regression Analysis (N=111)

    OR=odds ratio; CI=confidence interval; BMI=body mass index; LHRH=luteinizing hormone releasing hormone.

    Table 1.

    Table 2.

    Table 3.

    Table 4.

    Korean J Adult Nurs : Korean Journal of Adult Nursing

    ABOUT

    BROWSE ARTICLES 

    EDITORIAL POLICY

    FOR CONTRIBUTORS  

    © Korean Society of Adult Nursing.
    TOP